Abstract

Editorial

The risk of coronary heart disease varies with blood pressure grades and glycemic metabolism statues in a hypertensive

Ji-hong Hu*, Feng-feng Ding, Ji-hong Hu*, Zeng-wu Wang, Xin Wang, Chun-juan Yan, Ming-yan Ma and Xue-lian Chen

Published: 30 August, 2022 | Volume 6 - Issue 1 | Pages: 009-011

Coronary heart disease (CHD) is the leading cause of death worldwide [1]. In China, the prevalence of CHD has kept continually increasing, with the number of patients being approximately 11.39 million, at present [2] and CHD poses a substantial threat to human health. Hypertension and diabetes both are the major risk factors for CHD [2,3] and the risk of CHD in patients with coexisting hypertension and diabetes is higher than that in patients with either of the two diseases [4].

Read Full Article HTML DOI: 10.29328/journal.ach.1001029 Cite this Article Read Full Article PDF

References

  1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010. Erratum in: J Am Coll Cardiol. 2021 Apr 20;77(15):1958-1959. PMID: 33309175; PMCID: PMC7755038.
  2. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on Cardiovascular Health and Diseases in China 2021: an Updated Summary. Chin Circul J. 2022; 37(06): 553-578. doi:10.3969/j.issn.1000-3614.2022.06.001.
  3. Naito R, Miyauchi K. Coronary Artery Disease and Type 2 Diabetes Mellitus. Int Heart J. 2017 Aug 3;58(4):475-480. doi: 10.1536/ihj.17-191. Epub 2017 Jul 14. PMID: 28717115.
  4. Wang ZH, Yang TB. Cardio-cerebrovascular Complications Risk Difference of Hypertension with Diabetes in Independence vs Combination: A Cross-sectional Study among Residents in Changsha City in 2012. Chinese Journal of Health Statistics. 2021; 38(1):18-20+24. doi:10.3969/j.Issn.1002-2021.01.005.
  5. Zhang M, Wu J, Zhang X, Hu CH, Zhao ZP, Li C, Huang ZJ, Zhou MG, Wang LM. [Prevalence and control of hypertension in adults in China, 2018]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1780-1789. Chinese. doi: 10.3760/cma.j.cn112338-20210508-00379. PMID: 34814612.
  6. Liu J, Zhao D, Liu J, Qi Y, Sun J, Wang W. Prevalence of diabetes mellitus in outpatients with essential hypertension in China: a cross-sectional study. BMJ Open. 2013 Nov 20;3(11):e003798. doi: 10.1136/bmjopen-2013-003798. PMID: 24259390; PMCID: PMC3840347.
  7. Jie L. Investigation and analysis of vascular complications in patients with type 2diabetes mellitus and hypertension. Chinese Journal of Clinicians (Electronic Edition). 2014; 8(18): 3373-3375. doi:10.3877/cma.j.issn.1674-0785.2014.18.033.
  8. Riyahi-Alam S, Derakhshan A, Mansournia MA, Mansournia N, Almasi M, Azizi F, Hadaegh F. Blood pressure and cardiovascular morbidity risk in type 2 diabetes with hypertension over a decade of follow-up: evidence for J-shaped phenomenon. J Hum Hypertens. 2017 Jun;31(6):415-421. doi: 10.1038/jhh.2016.94. Epub 2017 Jan 26. PMID: 28124685.
  9. Wang HG. Analysis of clinical characteristics and vascular complications in patients with type 2 diabetes mellitus complicated with hypertension. Journal of Chinese Physician. 2014;16(11):1552-1553. doi:10.3760/cma.j.issn.1008-1372.2014.11.030.
  10. Bozorgmanesh M, Hadaegh F, Mohebi R, Ghanbarian A, Eskandari F, Azizi F. Diabetic population mortality and cardiovascular risk attributable to hypertension: a decade follow-up from the Tehran Lipid and Glucose Study. Blood Press. 2013 Oct;22(5):317-24. doi: 10.3109/08037051.2013.769294. Epub 2013 Mar 5. PMID: 23458066.
  11. Feng R, Wang Z, Cui Y, Wang X, Wang X. [Influential factors of treatment cost of antihypertensive drugs for hypertensive patient in community]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Mar;40(3):291-7. Chinese. doi: 10.11817/j.issn.1672-7347.2015.03.010. PMID: 25832531.
  12. Joint Committee for Guideline Revision. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019 Mar;16(3):182-241. doi: 10.11909/j.issn.1671-5411.2019.03.014. PMID: 31080465; PMCID: PMC6500570.
  13. Chinese Diabetes Society. Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2017 Edition). Chinese Journal of Diabetes. 2018; 10(1): 4-67. doi:10.3760/cma.j.issn.1674-5809.2018.01.003.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More